Current clinical pharmacology | 17 Feb 2021
T Wakabayashi, T Nakatsuji, H Kambara, I Niinomi, S Oyama, A Inada, S Ueno, M Uchida, K Iwanaga, T Iida and K Hosohata
Several studies reported that abnormal behavior was noted in pediatric patients receiving several drugs including neuraminidase inhibitors (NIs). However, information on drugs associated with abnormal behavior in a real-world setting remains limited. The purpose of this study was to clarify drugs associated with abnormal behavior using a spontaneous reporting system database.
* Data courtesy of Altmetric.com